Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
6
TMCI Quote, Financials, Valuation and Earnings
Last price:
$1.66
Seasonality move
:
-26.03%
Day range:
$1.82 - $2.20
52-week range:
$1.81 - $9.56
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.55x
P/B ratio:
1.36x
Volume:
1.3M
Avg. volume:
657K
1-year change:
-79.63%
Market cap:
$118.5M
Revenue:
$212.7M
EPS (TTM):
-$0.93
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$61.9M | -$0.14 | -10.08% | -1650% | $3.95 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.2M | $0.04 | 17.11% | -88.21% | $24.62 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
|
UFPT
UFP Technologies, Inc.
|
$149.1M | $2.24 | 4.56% | 2.72% | $324.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$1.86 | $3.95 | $118.5M | -- | $0.00 | 0% | 0.55x |
|
ABT
Abbott Laboratories
|
$116.35 | $133.39 | $202.3B | 31.30x | $0.63 | 2.06% | 4.59x |
|
ARAY
Accuray, Inc.
|
$0.58 | $2.53 | $68.6M | 149.00x | $0.00 | 0% | 0.15x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.62 | $24.62 | $2B | -- | $0.00 | 0% | 2.67x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.30 | $5.50 | $41.6M | -- | $0.00 | 0% | 4.85x |
|
UFPT
UFP Technologies, Inc.
|
$210.58 | $324.50 | $1.6B | 23.99x | $0.00 | 0% | 2.72x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
45.14% | 1.010 | 46.03% | 3.01x |
|
ABT
Abbott Laboratories
|
21.33% | 0.218 | 6.97% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.787 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.3% | 1.734 | 18.93% | 1.24x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -3.087 | 0.02% | 1.22x |
|
UFPT
UFP Technologies, Inc.
|
26.71% | 1.332 | 9.02% | 1.39x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TMCI
Treace Medical Concepts, Inc.
|
$50.4M | -$5.9M | -34.97% | -59.92% | -9.47% | -$10.4M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$130.4M | -$5.4M | -23.65% | -1092.5% | -2.52% | $5.7M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
|
UFPT
UFP Technologies, Inc.
|
$42M | $21M | 12.1% | 17.82% | 14.1% | $13M |
Treace Medical Concepts, Inc. vs. Competitors
-
Which has Higher Returns TMCI or ABT?
Abbott Laboratories has a net margin of -15.03% compared to Treace Medical Concepts, Inc.'s net margin of 15.71%. Treace Medical Concepts, Inc.'s return on equity of -59.92% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.80.62% -$0.15 $159.2M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About TMCI or ABT?
Treace Medical Concepts, Inc. has a consensus price target of $3.95, signalling upside risk potential of 125.81%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 14.65%. Given that Treace Medical Concepts, Inc. has higher upside potential than Abbott Laboratories, analysts believe Treace Medical Concepts, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.1 4 0 ABTAbbott Laboratories16 7 0 -
Is TMCI or ABT More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.741, suggesting its less volatile than the S&P 500 by 25.919%.
-
Which is a Better Dividend Stock TMCI or ABT?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.06% to investors and pays a quarterly dividend of $0.63 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios TMCI or ABT?
Treace Medical Concepts, Inc. quarterly revenues are $62.5M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. Treace Medical Concepts, Inc.'s net income of -$9.4M is lower than Abbott Laboratories's net income of $1.8B. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 31.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.55x versus 4.59x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.55x -- $62.5M -$9.4M ABTAbbott Laboratories4.59x 31.30x $11.5B $1.8B
-
Which has Higher Returns TMCI or ARAY?
Accuray, Inc. has a net margin of -15.03% compared to Treace Medical Concepts, Inc.'s net margin of -13.47%. Treace Medical Concepts, Inc.'s return on equity of -59.92% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.80.62% -$0.15 $159.2M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About TMCI or ARAY?
Treace Medical Concepts, Inc. has a consensus price target of $3.95, signalling upside risk potential of 125.81%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 337.23%. Given that Accuray, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Accuray, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.1 4 0 ARAYAccuray, Inc.2 0 0 -
Is TMCI or ARAY More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.192, suggesting its more volatile than the S&P 500 by 19.162%.
-
Which is a Better Dividend Stock TMCI or ARAY?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or ARAY?
Treace Medical Concepts, Inc. quarterly revenues are $62.5M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. Treace Medical Concepts, Inc.'s net income of -$9.4M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.55x versus 0.15x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.55x -- $62.5M -$9.4M ARAYAccuray, Inc.0.15x 149.00x $102.2M -$13.8M
-
Which has Higher Returns TMCI or ATEC?
Alphatec Holdings, Inc. has a net margin of -15.03% compared to Treace Medical Concepts, Inc.'s net margin of -10.21%. Treace Medical Concepts, Inc.'s return on equity of -59.92% beat Alphatec Holdings, Inc.'s return on equity of -1092.5%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.80.62% -$0.15 $159.2M ATECAlphatec Holdings, Inc.61.24% -$0.14 $632.1M -
What do Analysts Say About TMCI or ATEC?
Treace Medical Concepts, Inc. has a consensus price target of $3.95, signalling upside risk potential of 125.81%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 80.73%. Given that Treace Medical Concepts, Inc. has higher upside potential than Alphatec Holdings, Inc., analysts believe Treace Medical Concepts, Inc. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.1 4 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is TMCI or ATEC More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.994%.
-
Which is a Better Dividend Stock TMCI or ATEC?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or ATEC?
Treace Medical Concepts, Inc. quarterly revenues are $62.5M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $212.9M. Treace Medical Concepts, Inc.'s net income of -$9.4M is higher than Alphatec Holdings, Inc.'s net income of -$21.7M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.55x versus 2.67x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.55x -- $62.5M -$9.4M ATECAlphatec Holdings, Inc.2.67x -- $212.9M -$21.7M
-
Which has Higher Returns TMCI or PSTV?
Plus Therapeutics, Inc. has a net margin of -15.03% compared to Treace Medical Concepts, Inc.'s net margin of -316.61%. Treace Medical Concepts, Inc.'s return on equity of -59.92% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.80.62% -$0.15 $159.2M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About TMCI or PSTV?
Treace Medical Concepts, Inc. has a consensus price target of $3.95, signalling upside risk potential of 125.81%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1716.98%. Given that Plus Therapeutics, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.1 4 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is TMCI or PSTV More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.173%.
-
Which is a Better Dividend Stock TMCI or PSTV?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or PSTV?
Treace Medical Concepts, Inc. quarterly revenues are $62.5M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Treace Medical Concepts, Inc.'s net income of -$9.4M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.55x versus 4.85x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.55x -- $62.5M -$9.4M PSTVPlus Therapeutics, Inc.4.85x -- $1.4M -$4.4M
-
Which has Higher Returns TMCI or UFPT?
UFP Technologies, Inc. has a net margin of -15.03% compared to Treace Medical Concepts, Inc.'s net margin of 11.8%. Treace Medical Concepts, Inc.'s return on equity of -59.92% beat UFP Technologies, Inc.'s return on equity of 17.82%.
Company Gross Margin Earnings Per Share Invested Capital TMCITreace Medical Concepts, Inc.80.62% -$0.15 $159.2M UFPTUFP Technologies, Inc.28.18% $2.25 $578.4M -
What do Analysts Say About TMCI or UFPT?
Treace Medical Concepts, Inc. has a consensus price target of $3.95, signalling upside risk potential of 125.81%. On the other hand UFP Technologies, Inc. has an analysts' consensus of $324.50 which suggests that it could grow by 54.1%. Given that Treace Medical Concepts, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Treace Medical Concepts, Inc. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings TMCITreace Medical Concepts, Inc.1 4 0 UFPTUFP Technologies, Inc.1 2 0 -
Is TMCI or UFPT More Risky?
Treace Medical Concepts, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UFP Technologies, Inc. has a beta of 1.133, suggesting its more volatile than the S&P 500 by 13.317%.
-
Which is a Better Dividend Stock TMCI or UFPT?
Treace Medical Concepts, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UFP Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Treace Medical Concepts, Inc. pays -- of its earnings as a dividend. UFP Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TMCI or UFPT?
Treace Medical Concepts, Inc. quarterly revenues are $62.5M, which are smaller than UFP Technologies, Inc. quarterly revenues of $148.9M. Treace Medical Concepts, Inc.'s net income of -$9.4M is lower than UFP Technologies, Inc.'s net income of $17.6M. Notably, Treace Medical Concepts, Inc.'s price-to-earnings ratio is -- while UFP Technologies, Inc.'s PE ratio is 23.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Treace Medical Concepts, Inc. is 0.55x versus 2.72x for UFP Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TMCITreace Medical Concepts, Inc.0.55x -- $62.5M -$9.4M UFPTUFP Technologies, Inc.2.72x 23.99x $148.9M $17.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Mar 2
Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.
Buy
90
BNAI alert for Mar 2
Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.
Sell
36
WLDN alert for Mar 2
Willdan Group, Inc. [WLDN] is down 1.93% over the past day.
